MedTrace Logo

Extracorporeal Support for Respiratory Insufficiency (ECMO)

NCT00000562 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2013-11-26

No results posted yet for this study

Summary

To evaluate indications for the use and efficacy of extracorporeal membrane oxygenators (ECMO's) for the support of patients with potentially reversible acute respiratory failure.

Conditions

  • Acute Respiratory Failure
  • Lung Diseases

Interventions

PROCEDURE

extracorporeal membrane oxygenation

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Principal Investigators

  • Robert Bartlett · University of California, Irvine

  • Philip Drinker · Brigham and Women's Hospital

  • L. Edmunds · University of Pennsylvania

  • Alan Morris · University of Utah

  • E. Pierce · Icahn School of Medicine at Mount Sinai

  • Herbert Proctor · University of North Carolina

  • Arthur Thomas · University of California

  • Warren Zapol · Massachusetts General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT

Eligibility

Min Age
12 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1974-06-30
Completion
1979-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000562 on ClinicalTrials.gov